Intellia Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
LEONARD JOHN M.
Common Stock 5,000 N/A N/A
Option
RIVERA JOSE E officer: EVP, General Counsel
 Stock Option (right to buy) 10,000 N/A N/A
Option
RIVERA JOSE E officer: EVP, General Counsel
 Common Stock 10,000 N/A N/A
Sale
RIVERA JOSE E officer: EVP, General Counsel
 Common Stock 5,615 N/A N/A
Purchase
SCHIERMEIER ANDREW officer: EVP, Chief Operating O..
 Common Stock 7,500 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 6,686 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 6,686 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 6,686 N/A N/A
Sale
LEONARD JOHN M.
Common Stock 8,400 N/A N/A
Option
BELL GRAEME officer: EVP, Chief Financial O..
 Stock Option (Right to buy) 8,000 N/A N/A
Option
BELL GRAEME officer: EVP, Chief Financial O..
 Common Stock 8,000 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 39,245 N/A N/A
Sale
CARIBOU BIOSCIENCES, INC. 10 percent owner
 Common Stock 550,645 N/A N/A
Sale
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 10 percent owner
 Common Stock 1,523,000 N/A N/A
Sale
BERMINGHAM NESSAN director, officer: President & ..
 Common Stock 94,143 N/A N/A
Sale
BERMINGHAM NESSAN director, officer: President & ..
 Common Stock 131,140 N/A N/A
Sale
BERMINGHAM NESSAN director, officer: President & ..
 Common Stock 111,500 N/A N/A
Sale
CARIBOU BIOSCIENCES, INC. 10 percent owner
 Common Stock 1,048,846 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 80,000 N/A N/A
Sale
ATLAS VENTURE FUND IX, L.P. 10 percent owner
 Common Stock 80,000 N/A N/A
Sale
ATLAS VENTURE FUND IX, L.P. 10 percent owner
 Common Stock 40,000 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 40,000 N/A N/A
Sale
ATLAS VENTURE FUND IX, L.P. 10 percent owner
 Common Stock 30,000 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 30,000 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 5,504 N/A N/A
Sale
ATLAS VENTURE ASSOCIATES IX, L.P. 10 percent owner
 Common Stock 5,504 N/A N/A
Sale
ATLAS VENTURE ASSOCIATES IX, L.P. 10 percent owner
 Common Stock 15,628 N/A N/A
Sale
FORMELA JEAN FRANCOIS director
 Common Stock 15,628 N/A N/A
Purchase
TEMASEK HOLDINGS (PRIVATE) LTD 10 percent owner
 Common Stock 300,000 N/A N/A
Purchase
ORBIMED ADVISORS LLC director
 Common Stock 250,000 N/A N/A
Purchase
BAKER BROS. ADVISORS LP other: Former 10% owner
 Common Stock 200,000 N/A N/A
Purchase
GORDON CARL L director
 Common Stock 250,000 N/A N/A
Purchase
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 10 percent owner
 Common Stock 277,777 N/A N/A

Showing 250 to 283 of 283 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: